s6y
Company name or ticker
Search
enGene Therapeutics Inc.
3
Richton Kathleen P.: Initial statement of beneficial ownership of securities
Filed
Wednesday, July 22, 2026
Period
Jul 16, 2026
Accession number
0000929638-26-002666
Documents
form3.xml
3
POWER OF ATTORNEY
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header